Integra LifeSciences Holdings Corporation (IART)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 4.97B |
| Enterprise value | 6.21B |
| Trailing P/E | 32.49 |
| Forward P/E | 18.12 |
| PEG ratio (5-yr expected) | 1.51 |
| Price/sales (ttm) | 3.27 |
| Price/book (mrq) | 3.08 |
| Enterprise value/revenue | 3.98 |
| Enterprise value/EBITDA | 17.44 |
Trading information
Stock price history
| Beta (5Y monthly) | 1.10 |
| 52-week change 3 | -13.36% |
| S&P500 52-week change 3 | -5.12% |
| 52-week high 3 | 76.70 |
| 52-week low 3 | 55.16 |
| 50-day moving average 3 | 62.41 |
| 200-day moving average 3 | 66.77 |
Share statistics
| Avg vol (3-month) 3 | 486.94k |
| Avg vol (10-day) 3 | 348.56k |
| Shares outstanding 5 | 83.14M |
| Implied shares outstanding 6 | N/A |
| Float 8 | 72.11M |
| % held by insiders 1 | 13.08% |
| % held by institutions 1 | 92.39% |
| Shares short (28 Apr 2022) 4 | 4.48M |
| Short ratio (28 Apr 2022) 4 | 9.56 |
| Short % of float (28 Apr 2022) 4 | 7.18% |
| Short % of shares outstanding (28 Apr 2022) 4 | 5.39% |
| Shares short (prior month 30 Mar 2022) 4 | 4.55M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 2:1 |
| Last split date 3 | 03 Jan 2017 |
Financial highlights
Fiscal year
| Fiscal year ends | 30 Dec 2021 |
| Most-recent quarter (mrq) | 30 Mar 2022 |
Profitability
| Profit margin | 10.04% |
| Operating margin (ttm) | 18.40% |
Management effectiveness
| Return on assets (ttm) | 4.84% |
| Return on equity (ttm) | 9.96% |
Income statement
| Revenue (ttm) | 1.56B |
| Revenue per share (ttm) | 18.45 |
| Quarterly revenue growth (yoy) | 4.60% |
| Gross profit (ttm) | 976.97M |
| EBITDA | 407.22M |
| Net income avi to common (ttm) | 156.58M |
| Diluted EPS (ttm) | 1.84 |
| Quarterly earnings growth (yoy) | -27.50% |
Balance sheet
| Total cash (mrq) | 407.09M |
| Total cash per share (mrq) | 4.9 |
| Total debt (mrq) | 1.66B |
| Total debt/equity (mrq) | 102.93 |
| Current ratio (mrq) | 3.38 |
| Book value per share (mrq) | 19.43 |
Cash flow statement
| Operating cash flow (ttm) | 287.69M |
| Levered free cash flow (ttm) | 256.13M |
© 2022 Yahoo. All rights reserved.
